Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-04-04 Sale | 2023-04-06 4:37 pm | Jounce Therapeutics Inc. | JNCE | MURRAY RICHARD Director | 39,228 | $1.85 | $72,572 | 188,779 (Direct) | View |
| 2023-01-09 Sale | 2023-01-11 8:32 pm | Jounce Therapeutics Inc. | JNCE | MURRAY RICHARD CEO and President | 45,070 | $1.111 | $50,075 | 228,007 (Direct) | View |
| 2022-01-07 Sale | 2022-01-11 8:57 pm | Jounce Therapeutics Inc. | JNCE | MURRAY RICHARD CEO and President | 37,294 | $6.883 | $256,696 | 185,577 (Direct) | View |
| 2021-01-21 Sale | 2021-01-25 5:38 pm | Jounce Therapeutics Inc. | JNCE | MURRAY RICHARD CEO and President | 33,518 | $12.06 | $404,227 | 805,540 (Direct) | View |
| 2021-01-15 Sale | 2021-01-20 8:38 pm | Jounce Therapeutics Inc. | JNCE | MURRAY RICHARD CEO and President | 86,482 | $9.6927 | $838,243 | 2,309,396 (Direct) | View |
| 2021-01-07 Sale | 2021-01-11 06:21 am | Jounce Therapeutics Inc. | JNCE | MURRAY RICHARD CEO and President | 21,999 | $6.8889 | $151,549 | 140,371 (Direct) | View |
| 2020-01-07 Sale | 2020-01-10 08:53 am | Jounce Therapeutics Inc. | JNCE | MURRAY RICHARD CEO and President | 7,150 | $7.78 | $55,627 | 87,360 (Direct) | View |
| 2019-12-23 Sale | 2019-12-26 5:08 pm | Jounce Therapeutics Inc. | JNCE | MURRAY RICHARD CEO and President | 40,000 | $8.37 | $334,800 | 879,679 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-05-03 Disposition | 2023-05-04 07:44 am | N/A N/A | Jounce Therapeutics Inc. | JNCE | MURRAY RICHARD Director | 1,883,269 | $0 | 1 (Direct) | View |
| 2023-05-03 Equity Swap | 2023-05-04 07:44 am | N/A N/A | Jounce Therapeutics Inc. | JNCE | MURRAY RICHARD Director | 188,778 | $0 | 1 (Direct) | View |
| 2022-02-01 Option Award | 2022-02-03 7:37 pm | N/A 2032-02-01 | Jounce Therapeutics Inc. | JNCE | MURRAY RICHARD CEO and President | 262,500 | $0 | 448,077 (Direct) | View |
| 2021-02-01 Option Award | 2021-02-03 5:48 pm | N/A 2031-02-01 | Jounce Therapeutics Inc. | JNCE | MURRAY RICHARD CEO and President | 247,500 | $0 | 387,871 (Direct) | View |
| 2021-01-21 Exercise | 2021-01-25 5:38 pm | N/A N/A | Jounce Therapeutics Inc. | JNCE | MURRAY RICHARD CEO and President | 33,518 | $0.48 | 805,540 (Direct) | View |
| 2021-01-21 Exercise | 2021-01-25 5:38 pm | N/A 2024-06-26 | Jounce Therapeutics Inc. | JNCE | MURRAY RICHARD CEO and President | 33,518 | $0 | 805,540 (Direct) | View |
| 2021-01-15 Exercise | 2021-01-20 8:38 pm | N/A N/A | Jounce Therapeutics Inc. | JNCE | MURRAY RICHARD CEO and President | 86,482 | $0.48 | 2,309,396 (Direct) | View |
| 2021-01-15 Exercise | 2021-01-20 8:38 pm | N/A 2024-06-26 | Jounce Therapeutics Inc. | JNCE | MURRAY RICHARD CEO and President | 86,482 | $0 | 2,309,396 (Direct) | View |
| 2020-02-03 Option Award | 2020-02-04 9:01 pm | N/A 2030-02-03 | Jounce Therapeutics Inc. | JNCE | MURRAY RICHARD CEO and President | 225,020 | $0 | 312,380 (Direct) | View |
| 2019-12-23 Exercise | 2019-12-26 5:08 pm | N/A 2024-06-26 | Jounce Therapeutics Inc. | JNCE | MURRAY RICHARD CEO and President | 40,000 | $0.48 | 879,679 (Direct) | View |